Feedback / Questions
BDC-3042 - Bolt Biotherap
trastuzumab imbotolimod (BDC-1001) - Bolt Biotherap
https://www.globenewswire.com/news-release/2024/05/14/2881877/0/en/Bolt-Biotherapeutics-Reports-First-Quarter-2024-Results-Announces-Strategic-Pipeline-Prioritization-and-Changes-to-Leadership-Team.html
May 14, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next